The market climbed Thursday as earnings results painted a steady picture of retail health for the fourth quarter of 2024. A gaggle of stocks on the S&P 500 hit 52-week highs. Just past 4 pm ET the$S&P 500 Index (.SPX.US)$traded +0.36%, the$Dow Jones Industrial Average (.DJI.US)$fell 0.28%, and the$Nasdaq Composite Index (.IXIC.US)$climbed 0.51%. MACRO Thursday macro showed 219k people filed for unemployment in the US l...
Markets climbed after earnings calls came out from retailers and drug makers- one stock dropped 21%, and you'll never guess why. Happy Thursday investors; it's February 6th, so let's check out the Live Stock News. $Ralph Lauren (RL.US)$climbed 15% at open after the company reported an 11% increase in quarterly revenue and raised its fiscal-year outlook.$Tapestry (TPR.US)$soared 14% after the luxury fashion company reported ...
The market decisively fell Friday, with the indexes pulling back. On Thursday,$Apple (AAPL.US)$hit an all-time high of $260, just below the $4 T market cap. Friday, the market pulled back, with other big tech names joining Apple in pilling down indices. It is looking bleak for a "Santa Clause Rally" that sees the last seven sessions or so of the trading year end in an overall gain. After the 4 pm close, the$Dow Jones Industrial Average (.DJI.US)$fell 0.77...
Sundar Subbarama
:
We still have a week to go for the Santa rally. Expecting a race to the top next Tuesday through Friday. Well Wednesday will be fireworks all around the World.
$Esperion Therapeutics (ESPR.US)$Acquiring Esperion Therapeutics could be a strategic move for a big pharmaceutical company for several compelling reasons. Here are the main factors that suggest an acquisition could be beneficial for a larger player in the pharmaceutical industry: 1. Unique Market Position in Statin Alternatives – Addressing Statin Intolerance: There are millions of statin...
Bristol-Myers Squibb Stock Forum
Major Clinical Trial Results: Sotyktu Maintains 46% Complete Skin Clearance After 5 Years
Just past 4 pm ET the $S&P 500 Index (.SPX.US)$ traded +0.36%, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.28%, and the $Nasdaq Composite Index (.IXIC.US)$ climbed 0.51%.
MACRO
Thursday macro showed 219k people filed for unemployment in the US l...
Happy Thursday investors; it's February 6th, so let's check out the Live Stock News.
$Ralph Lauren (RL.US)$ climbed 15% at open after the company reported an 11% increase in quarterly revenue and raised its fiscal-year outlook. $Tapestry (TPR.US)$ soared 14% after the luxury fashion company reported ...
has earning tho
loading...
Finding mispriced high quality company + opportunistic trade.
Top 5 Winners
Top 5 Laggards
After the 4 pm close, the $Dow Jones Industrial Average (.DJI.US)$ fell 0.77...
$Ionis Pharmaceuticals (IONS.US)$ : 🤔
⇨ IONIS-APOCIII-LRx (Olezarsen)
‣ FCS (Familial chylomicronemia syndrome)
‣ PDUFA: 12/19/24 (NDA)
🗓️ Last Week’s PDUFA Decisions:
$Checkpoint Therapeutics (CKPT.US)$ : Approved 12/13/24 ✅
⇨ UNLOXCYT (cosibelimab-ipdl)
‣ metastatic or locally advanced cSCC (cutaneous squamous cell carcinoma)
‣ PDUFA: 12/28/24 (resubmitted BLA)
$Neurocrine Biosciences (NBIX.US)$ : Approved 12/13/24 ✅
⇨ CRENESSITY™ (crin...
1. Unique Market Position in Statin Alternatives
– Addressing Statin Intolerance: There are millions of statin...
$Ionis Pharmaceuticals (IONS.US)$ ⇨ IONIS-APOCIII-LRx (Olezarsen)
$ZLDPF ⇨ Glepaglutide
$Rhythm Pharmaceuticals (RYTM.US)$ ⇨ IMCIVREE™ (Setmelanotide)
$Mirum Pharmaceuticals (MIRM.US)$ ⇨ Chenodal® (chenodiol)
$Checkpoint Therapeutics (CKPT.US)$ ⇨ Cosibelimab (CK-301)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont capsule
$Bristol-Myers Squibb (BMY.US)$ ⇨ Opdivo® Subcutaneous (nivolumab + hyaluronidase)
$Neurocrine Biosciences (NBIX.US)$ ⇨ Crinecerfont oral solution
$BeiGene (BGNE.US)$ ⇨ Tisleli...
No comment yet